Karolinska Institutet cooperates successfully with a number of different companies. Together we can deliver new services, products and knowledge that help improve human health.
KI and AstraZeneca have a joint translational research center for metabolic and cardiovascular diseases.
Novo Nordisk and KI cooperate in diabetes research where the focus is on developing new possible treatments for patients.
The collaboration between KI and Janssen Pharmaceuticals NV uses observational studies for understanding effects of disease and treatment.
KI Holding AB and Johnson & Johnson Innovations has a collaboration to meet the needs of entrepreneurs in the pharmaceutical, medical technology and healthcare sectors.
KI and MSD collaborate on the use of real world data to help inform future medical and clinical research, product development and economic models.
The KI collaboration with Ferring at the Center for Translational Microbiome Research is focused on mapping the human microbiome in health and disease.